Soleno Therapeutics (SLNO) EBIT Margin Growth (1y) (2016 - 2017)

Soleno Therapeutics (SLNO) EBIT Margin Growth (1y) (2016 - 2017) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (1y) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1,552.00
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1,536.00
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -170.00
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 1,276.00
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Soleno Therapeutics 874.25 Mn 618.67 Mn 93.41 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2017 -18.21 Mn
Mar 31, 2017 43,558.00
Dec 31, 2016 77,868.00
Sep 30, 2016 69,049.00
Jun 30, 2016 -11.16 Mn
Mar 31, 2016 1.01 Mn